We are an internationally leading centre for research, teaching and clinical practice in psychiatry and population-based neuroscience. The Department’s senior staff support several research groups, covering various aspects of mental health and disorder throughout the life course.
You can read our mission statement here.
In the most recent UK Government Research Assessment Exercise (2008) we achieved the highest quality ratings for the strength-in-depth of our research over the period since the previous RAE in 2001, where we were rated as 5*. See the results here. In 2010 the Times Higher Education Supplement ranked Cambridge first in European Psychiatry and Psychology over the decade.
We run and collaborate in a wide number of other inter-disciplinary research initiatives, including the CLAHRC for Cambridgeshire and Peterborough and the Cambridge Biomedical Research Centre (BRC). We also actively collaborate with other University departments, clinical partners in the NHS, other national and international academic institutions, the UK Government and various policy groups, as well as service users and carers.
The Department comprises around 140 staff and post-graduate students distributed across four sites: the Herchel Smith Building for Brain & Mind Sciences on the Cambridge Biomedical Campus, Douglas House on Trumpington Road, Addenbrooke’s Hospital and the Downing Site in central Cambridge. See our locations here.
We are part of the University School of Clinical Medicine. The School has been awarded an Athena Swan Silver Award. You can read more about this by clicking on the badge below.
A study from the department of Psychiatry has found similarities in the brains and cognitive profiles of adults with ADHD and their unaffected first degree relatives. ADHD is known to be a highly heritable disorder. However, studies searching for genes that increase the likelihood of developing ADHD have yielded inconsistent results. Supervised by Professor Barbara Sahakian at the behavioural and clinical neuroscience institute (BCNI), the research team set out to determine whether there are … [Read More...]
Until recently, the problems with attention and hyperactivity experienced by people with Attention Deficit Hyperactivity Disorder (ADHD) were thought to be caused by dysregulation of dopamine, which is a chemical in the brain that is involved in processes such as reward-driven behaviour and … [Read More...]